Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Georges Leclercq
Profile
Projects
Publications
Activities
Awards & Distinctions
Results
:
ALL
(
17
)
Order By :
Chronological by starting year (new to old)
Title (a-z)
Chronological by starting year (new to old)
As
Promotor
01 April 2019 → 31 March 2020
Strengthening the UGent patent position on an improved cultivation method for adoptive cell therapies (immuno-oncology).
Funding: Regional and community funding: Industrial Research Fund
01 January 2018 → 31 December 2019
Innate lymphoid cells in multiple sclerosis: implications of genetic risk variants
Funding: Funding by bilateral agreement (private and foundations)
01 January 2017 → 31 December 2020
Exploring important milestones in the differentiation of human natural killer cells and innate lymphoid cells: from stem cell to effector.
Fellows: Sigrid Wahlen
Funding: Research Foundation - Flanders (FWO)
01 January 2017 → 31 December 2020
The regulatory role of the transcription factors T-bet and Eomes in development and function of human NK cells and innate lymphoid cells
Fellows: Laura Kiekens
Funding: Research Foundation - Flanders (FWO)
01 January 2017 → 31 December 2020
Transcriptional regulation of differentiation of human natural killer and innate lymphoid cells.
Funding: Research Foundation - Flanders (FWO)
01 January 2015 → 31 December 2018
A new mechanism of tumor escape from innate-like T lymphocytes
Funding: Funding by bilateral agreement (private and foundations)
01 October 2014 → 24 June 2019
Transcriptional regulation of human natural killer cell and innate lymphoid cell differentiation
Fellows: Sylvie Taveirne
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 January 2013 → 31 December 2018
The role of the Ly49E receptor in the differentiation and function of natural killer celles and innate-like T
Funding: Research Foundation - Flanders (FWO)
01 January 2013 → 31 December 2016
The role of the transcription factors Tox and Id2 in the development of human natural killer cells
Fellow: Mandy Vanhees
Funding: Regional and community funding: IWT/VLAIO
01 October 2012 → 01 October 2014
The role of the transcription factors Ets-1, E4BP4 and GATA-3 in the development of human natural killer cells.
Funding: Regional and community funding: Special Research Fund
15 June 2012 → 30 June 2016
Yellow/Green laser upgrade for LSRII analyser and FACSARIAII sorter flow cytometers
Funding: Regional and community funding: Special Research Fund
01 October 2011 → 30 June 2016
Role of the Ly49E receptor in the regulation of the immune response of NK cells and skin epithelium-localized Vgamma3 T cells
Fellow: Jessica Filtjens
Funding: Regional and community funding: IWT/VLAIO
01 October 2011 → 30 June 2016
The role of the Ly49E receptor in mucosal immunity and intestinal tumour immune response
Fellow: Aline Van Acker
Funding: Regional and community funding: IWT/VLAIO
01 January 2011 → 31 December 2014
Impact of Ly49E receptor expression on tumor immune surveillance in vivo.
Funding: Funding by bilateral agreement (private and foundations)
01 January 2009 → 31 December 2014
Regulation of differentiation and function of natural killer cells and epithelial-localised T lymphocytes
Funding: Research Foundation - Flanders (FWO)
01 January 2007 → 31 December 2010
A novel function of urokinase plasminogen activator as a ligand for natural killer receptors: exploration of receptor biology and implications in tumor immunity
Funding: Funding by bilateral agreement (private and foundations)
As
Copromotor
01 January 2009 → 31 December 2010
A flow cytometer to perform multiparameter sorting, including single-cell deposition under biohazard conditions L2
Funding: Regional and community funding: Special Research Fund